Governance Changes

PHP Ventures Acquisition Corp.: Amended certificate of incorporation to extend business combination deadline from February 16, 2023 to up to August 16, 2023 with monthly extensions at $0.0625 per share (effective 2022-12-30).

“the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation giving the Company the right to extend the date by which the Company must (i) consummate a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination involving the Company and one or more businesses (a “ Business Combination ”), (ii) cease its operations if it fails to complete such business combination, and (iii) redeem or repurchase 100% of the Company’s Class A common stock included as part of the units sold in the Company’s initial public offering that closed on August 16, 2021 (the “ IPO ”) from February 16, 2023 (the “ Termination Date ”) by up to six (6) one-month extensions to August 16, 2023 at a price of $0.0625 per share per month, commencing February 16, 2023, our current Termination Date”

International Media Acquisition Corp.: Extended the deadline to consummate a business combination by three months to May 2, 2023, with an option for three additional one-month extensions until August 2, 2023 (effective 2023-02-02).

“The Charter Amendment changed the date by which IMAQ must consummate an initial business combination for an additional three (3) months, from February 2, 2023 to May 2, 2023, with an ability to further extend by three (3) additional one (1) month periods until August 2, 2023.”

Talon 1 Acquisition Corp: Approved an amendment to the Amended and Restated Memorandum and Articles of Association to extend the deadline to consummate a business combination from February 8, 2023 up to November 8, 2023, through up to nine one-month extensions (effective 2023-02-02).

“At the Extraordinary General Meeting, the shareholders of the Company approved an amendment (the “Charter Amendment”) to the Company’s Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate an initial business combination up to nine (9) times for an additional one (1) month each time from February 8, 2023 to November 8, 2023 (which is 24 months from the closing of the Company’s initial public offering). Under Cayman Islands law, the Charter Amendment took effect upon approval by the shareholders.”

Amergent Hospitality Group Inc.: Filed a Certificate of Designation for Series B Convertible Preferred Stock, specifying its terms as part of the Certificate of Incorporation (effective 2023-02-01).

“On February 1, 2023, Amergent filed a Certificate of Designation of the Preferences, Rights and Limitations Series B Convertible Preferred Stock (“Certificate”) with the Secretary of State of Delaware, which becomes effective upon filing.”

Limitless X Holdings Inc.: Adopted amended and restated bylaws with changes to special meetings, quorum, board vacancies, director removal, amendment authority, exclusive forum, virtual meetings, advance notice, and indemnification (effective 2023-01-29).

“On January 29, 2023, the Board of Directors (the “Board”) of Limitless X Holdings, Inc. (the “Company) approved and adopted the “AMENDED AND RESTATED BYLAWS OF LIMITLESS X HOLDINGS INC.” (hereinafter referred to as the “A&R Bylaws”) pursuant to their authority under Article VI of the Company’s Amended and Restated Certificate of Incorporation (the “A&R Certificate”).”

Quad/Graphics, Inc.: Increased the size of the Board from nine directors to ten directors by amending Section 3.01 of Article III of the Amended Bylaws (effective 2023-01-31).

“the Board approved an amendment to Section 3.01 of Article III of the Company’s Amended Bylaws to increase the size of the Board from nine directors to ten directors. This amendment was effective on January 31, 2023.”

Commercial Vehicle Group, Inc.: Amended and restated bylaws to update advance notice, proxy card color, Delaware law, exclusive forum, and gender-neutral terms (effective 2023-02-01).

“On February 1, 2023, the Board of Directors (the “Board”) of Commercial Vehicle Group, Inc. (the “Company”) approved the amendment and restatement of the Company’s Amended and Restated Bylaws (the “Bylaws”), effective immediately.”

UNITED STATES STEEL CORP: Amended and restated By-Laws to update procedural and disclosure requirements for stockholder director nominations to comply with universal proxy rules (effective 2023-01-31).

“On January 31, 2023, the Board of Directors (the “Board”) of United States Steel Corporation (the “Corporation”) amended and restated the Corporation’s By-Laws (as amended and restated, the “Amended and Restated By-Laws”), effective immediately, to, among other things, update provisions relating to procedural and disclosure requirements for stockholder director nominations to address the universal proxy rules adopted by the Securities and Exchange Commission, as set forth in Rule 14a-19 of the Securities Exchange Act of 1934, as amended (the “Universal Proxy Card Rules”).”

PIXELWORKS, INC: The Board approved and adopted amended and restated bylaws effective January 28, 2023, with various procedural and disclosure enhancements (effective 2023-01-28).

“On January 28, 2023, the board of directors (the “Board”) of Pixelworks, Inc. (the “Company”) approved and adopted amended and restated bylaws of the Company (the “Amended and Restated Bylaws”).”

MACERICH CO: Amended and restated Bylaws to address universal proxy rules, enhance stockholder nomination and proposal procedures, and make technical updates (effective 2023-01-26).

“On January 26, 2023, the Board of Directors (the “Board”) of The Macerich Company (the “Company”) amended and restated the Company’s Amended and Restated Bylaws (as so amended and restated, the “Bylaws”), to, among other things: • address the universal proxy rules adopted by the U.S. Securities and Exchange Commission, by clarifying that no person may solicit proxies in support of a director nominee other than the Board’s nominees unless such person has complied with Rule 14a-19 under the Securities Exchange Act of 1934, as amended, including applicable notice and solicitation requirements; • enhance procedural mechanics and disclosure requirements in connection with stockholder nominations of directors and submissions of proposals regarding other business at stockholder meetings, including requiring additional background information and disclosures regarding proposing stockholders, proposed nominees and business, and other persons related to a stockholder’s solicitation of proxies; an”

STAAR SURGICAL CO: Amended and restated bylaws to update procedural mechanics, enhance director nominee requirements, add exclusive forum provision, etc (effective 2023-01-26).

“On January 26, 2023, the Board of Directors of STAAR Surgical Company (the “Company”) adopted amended and restated bylaws of the Company (the bylaws, as so amended and restated, the "Amended and Restated Bylaws"), effective immediately.”

DYNATRONICS CORP: Approved and filed Articles of Amendment to effect a 1-for-5 reverse stock split of common stock (effective 2023-02-01).

“The Company’s board of directors set the split ratio in the reverse stock split at 1-for-5 and approved and authorized the filing of the Articles of Amendment to effect the reverse stock split with the Utah Department of Commerce, Division of Corporations and Commercial Code. The Articles of Amendment and reverse stock split became effective at 5:00 p.m. Eastern Standard Time on February 1, 2023”

Constellation Acquisition Corp I: Amended articles of association to extend business combination deadline from January 29, 2023 to April 29, 2023, with option for further monthly extensions up to January 29, 2024 (effective 2023-01-31).

“Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On January 27, 2023, the Company held the Extension Meeting to amend the Company’s amended and restated memorandum and articles of association (the “ Articles Amendment ”) to extend the date (the “ Termination Date ”) by which the Company has to consummate a business combination from January 29, 2023 (the “ Original Termination Date ”) to April 29, 2023 (the “ Articles Extension Date ”) and to allow the Company, without another shareholder vote, to elect to extend the Termination Date to consummate a business combination on a monthly basis for up to nine times by an additional one month each time after the Articles Extension Date, by resolution of the Company’s board of directors if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until January 29, 2024, or a total of up to twelve months after the Original Termination Date, unless the closing of the”

Future Health ESG Corp.: Approval and filing of Charter Amendment to decrease authorized common shares from 500,000,000 to 26,000,000 (effective 2023-01-31).

“At the Meeting, the Company’s stockholders approved an amendment (the “ Charter Amendment ”) to the Company’s Amended and Restated Certificate of Incorporation to decrease the number of authorized shares of common stock, par value $0.0001 per share, from 500,000,000 to 26,000,000.”

BlueRiver Acquisition Corp.: Amended the memorandum and articles of association to extend the termination date for a business combination from February 2, 2023 to August 2, 2023 (effective 2023-01-31).

“to amend (the “ Extension Proposal ”) the Company’s amended and restated memorandum and articles of association to extend from February 2, 2023 to August 2, 2023, the date (the “ Termination Date ”) by which, if the Company has not consummated a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving the Company, with one or more businesses or entities (a “ Business Combination ”), the Company must (a) cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Class A ordinary shares sold in the Company’s initial public offering (the “ Public Shares ”); and (c) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and i”

EBET, Inc.: Amended definition of 'Exempt Issuance' in Series A Convertible Preferred Stock and filed amended certificate of designation (effective 2023-02-01).

“On February 1, 2023, the holders of a majority of the Preferred Stock approved an additional amendment to the terms of the Preferred Stock to amend the definition of “Exempt Issuance” to permit the issuance of up to $10.0 million in securities (excluding amounts received upon the exercise of warrants issued in connection with such securities) issued prior to April 28, 2023 in public or private offerings of Company common stock (or common stock equivalents) at a price per security that is not less than the “Minimum Price” as defined in NASDAQ Rule 5635(d) on the date of the offering, which issuances may include warrant coverage in such amounts as determined by the Company. On February 1, 2023, the Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock was filed in the State of Nevada.”

EBET, Inc.: Extended adjustment dates of Series A Convertible Preferred Stock and filed amended certificate of designation (effective 2023-01-31).

“On January 30, 2023, the holders of a majority of the Preferred Stock approved an amendment to the terms of the Preferred Stock to: (i) extend the initial Adjustment Date from January 31, 2023 to April 28, 2023; and (ii) to extend the second Adjustment Date from April 15, 2023 to July 31, 2023; and (iii) to add a third Adjustment Date of October 31, 2023. Notwithstanding the foregoing, the adjusted Preferred Conversion Price may not be less than $0.71, unless the terms of the new adjustment dates are approved by the shareholders of the Company, as required pursuant to applicable rules and regulations of NASDAQ. The Company agreed to submit for a vote the approval the terms of the new adjustment dates at its next meeting of shareholders and use its reasonable best efforts to solicit its shareholders’ approval of such vote. On January 31, 2023, the Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock was filed”

Applied UV, Inc.: Filed Certificate of Designations for Series C Preferred Stock, amending the articles of incorporation (effective 2023-01-25).

“On January 25, 2023, the Company filed the Certificate of Designations, Rights, and Preferences for the Series C Preferred Stock with the Secretary of State of the State of Delaware, which became effective upon acceptance for record.”

Applied UV, Inc.: Filed Certificate of Designations for Series B Preferred Stock, amending the articles of incorporation (effective 2023-01-25).

“On January 25, 2023, the Company filed the Certificate of Designations, Rights, and Preferences for the Series B Preferred Stock with the Secretary of State of the State of Delaware, which became effective upon acceptance for record.”

DoorDash, Inc.: Board approved Amended and Restated Bylaws to align with Delaware law, update universal proxy rules, and make clarifying changes (effective 2023-01-30).

“On January 30, 2023, the Board of Directors (the “Board”) of DoorDash, Inc. (the “Company”) approved the Company’s Amended and Restated Bylaws (the “Amended Bylaws”), effective January 30, 2023.”

Ensysce Biosciences, Inc.: Creation of Series A Preferred Stock via a dividend declared on January 31, 2023, effective upon filing of a Certificate of Designation (effective 2023-01-31).

“On January 31, 2023, the Board of Directors (the “Board”) of Ensysce Biosciences Inc. (the “Company”) declared a dividend of 0.001 of a share of Series A Preferred Stock, par value $0.0001 per share (“Series A Preferred Stock”), for each outstanding share of the Company’s common stock, par value $0.0001 per share (the “Common Stock”) to stockholders of record at 5:00 pm Eastern Time on February 13, 2023 (the “Record Date”).”

Electromedical Technologies, Inc: Increased authorized shares to two billion and one, including Common Stock, Series A Preferred, and Series B Preferred; par value $0.00001 per share (effective 2023-01-31).

“On January 31, 2023, the board of directors approved a resolution to amend the Company’s Certificate of Incorporation to: (1) increase the Company’s authorized shares to two billion and one shares of capital stock, including: one hundred and ninety-nine million shares designated as “Common Stock,” with a par value of $0.00001 per share; one million shares designated as “Series A Preferred Shares,” par value $0.00001 per share; and one share designated as “Series B Preferred Shares,” par value $0.00001 per share.”

My City Builders, Inc.: Changed corporate name to My City Builders, Inc. via merger with wholly owned subsidiary (effective 2023-01-31).

“On January 31, 2023, the Company changed its corporate name to My City Builders, Inc., through the merger of the Company with its wholly owned subsidiary, My City Builders, Inc., a Nevada corporation (the “Subsidiary”).”

Arq, Inc.: Designation of 8,900,000 shares of preferred stock as Series A Convertible Preferred Stock and filing of Certificate of Designations (effective 2023-02-01).

“On February 1, 2023, the Company, in connection with the issuance of its Series A Preferred Stock described above, designated 8,900,000 shares of its authorized and unissued preferred stock as Series A Convertible Preferred Stock and filed a Certificate of Designations of Preferred Stock with the Secretary of State of the State of Delaware, which is attached hereto as Exhibit 3.1 and incorporated by reference herein.”

Statera Biopharma, Inc.: Established Series B Preferred Stock and filed Certificate of Designation setting forth preferences, rights, and limitations (effective 2023-01-26).

“On January 26, 2023, the board of directors (the "Board") of Statera Biopharma, Inc. (the "Company") declared a dividend of one one-thousandth of a share of Series B Preferred Stock, par value $0.005 per share ("Series B Preferred Stock"), for each outstanding share of the Company's common stock, par value $0.005 per share ("Common Stock") to stockholders of record at 5:00 p.m. Eastern Time on February 1, 2023 (the "Record Date"). Series B Certificate of Designation The preferences, rights, limitations and other matters relating to the Series B Preferred Stock are set forth in a Certificate of Designation of Preferences, Rights and Limitations of Series B Preferred Stock (the "Certificate of Designation").”

WESTERN DIGITAL CORP: Filing of Certificate of Designations to establish terms of Preferred Stock.

“On the Closing Date, the Company filed the Certificate of Designations with the Secretary of State of the State of Delaware to establish and fix the terms of the Preferred Stock.”

TIMBERLAND BANCORP INC: Bylaws amended to increase number of directors from eight to nine (effective 2023-02-01).

“On February 1, 2023, the Company’s Board of Directors amended the Company’s Bylaws by increasing the number of directors from eight (8) to nine (9), in connection with the addition of Mr. Brydon to the Board of Directors.”

RB GLOBAL INC.: Articles of Amendment to Articles of Amalgamation became effective, establishing rights, preferences, and privileges of Preferred Shares (effective 2023-02-01).

“The rights, preferences and privileges of the Preferred Shares are set forth in the articles of amendment of the Company (the “ Articles of Amendment ”), amending the Company’s Articles of Amalgamation. The Articles of Amendment became effective on February 1, 2023”

COLUMBIA SPORTSWEAR CO: Amended and restated bylaws to enhance procedural mechanics for shareholder director nominations, require proxy card color other than white, and allow exclusion of nominees for false information (effective 2023-01-27).

“On January 27, 2023, the Board of Directors (the “Board”) of Columbia Sportswear Company (the “Company”) approved and adopted amended and restated bylaws (the “2023 Amended and Restated Bylaws”), which became effective the same day.”

OneSpan Inc.: Amended and restated bylaws adopted effective January 30, 2023, modifying provisions related to stockholder meetings, director nominations, exclusive forum, and procedural updates (effective 2023-01-30).

“On January 30, 2023, the Board of Directors of OneSpan Inc. (the “Company”) unanimously adopted amended and restated by-laws of the Company (as so amended and restated, the “Bylaws”).”

WOLF ENERGY SERVICES INC.: Company changed its name to Wolf Energy Services Inc. via Articles of Amendment to its Articles of Incorporation (effective 2023-01-30).

“On January 30, 2023, Enviro Technologies U.S., Inc. (the "Company") filed Articles of Amendment to its Articles of Incorporation (the "Articles of Amendment") with the Secretary of State of the State of Florida to change the Company’s name to Wolf Energy Services Inc.”

SOUTH JERSEY GAS Co: Bylaws of surviving corporation amended and restated to match Merger Sub's bylaws.

“At the Effective Time, the bylaws of the Surviving Corporation were amended and restated to be the same as the bylaws of Merger Sub as in effect immediately prior to the Effective Time and otherwise in accordance with the terms of the Merger Agreement, and is filed herewith as Exhibit 3.2 to this Current Report on Form 8-K and are incorporated herein by reference.”

SOUTH JERSEY GAS Co: Certificate of incorporation of surviving corporation amended and restated to match Merger Sub's certificate.

“At the Effective Time, the certificate of incorporation of the Surviving Company was amended and restated to be the same as the certificate of incorporation of Merger Sub as in effect immediately prior to the Effective Time and otherwise in accordance with the terms of the Merger Agreement, and is filed herewith as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.”

DOLLAR TREE, INC.: Amendments to the Amended and Restated By-Laws of the Company, including provisions on stockholder nominations and compliance with Rule 14a-19 (effective 2023-01-30).

“On January 30, 2023, the Board of Directors (the “Board”) of Dollar Tree, Inc. (the “Company”) approved amendments to the Amended and Restated By-Laws of the Company (the “By-Laws”), effective immediately.”

B2Digital, Inc.: Amended Certificate of Designation for Series B Convertible Preferred Stock to revise voting, liquidation, dividend, and redemption provisions, including changing voting rights to 360 votes per share and clarifying no liquidation preference, dividends, or redemption (effective 2023-01-24).

“On January 24, 2023, with Mr. Bell abstaining, the board of directors of the Company approved the filing of an amendment to the Certificate of Designation of the Series B Convertible Stock pursuant to which the section titled “ Voting, Liquidation, Dividends, and Redemption ” was revised to the following: “ Voting, Liquidation, Dividends, and Redemption . On all matters to be voted on by the holders of Common Stock, the Holders of Series B Preferred Stock shall be entitled to three hundred and sixty (360) votes for each share of Series B Preferred Stock held of record.”

SCHWAB CHARLES CORP: Board approved amendment and restatement of bylaws with changes including meeting flexibility, DGCL conforming updates, proxy rules, director requirements, and other clarifications (effective 2023-01-26).

“On January 26, 2023, the Board of Directors (the “Board”) of The Charles Schwab Corporation (“CSC”) approved the amendment and restatement of CSC’s Amended and Restated Bylaws (the “Bylaws”), effective immediately.”

Catalyst Partners Acquisition Corp.: Accelerated the deadline to complete a business combination from May 20, 2023 to January 31, 2023 (effective 2023-01-31).

“(i) an amendment (the “Charter Amendment”) to the Company’s Amended and Restated Memorandum and Articles of Association (the “Charter”) to accelerate the date by which the Company must cease all operations, except for the purpose of winding up, if it fails to complete a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, from May 20, 2023 (the “Original Termination Date”) to January 31, 2023 (the “Amended Termination Date”)”

Global System Dynamics, Inc.: Extended the deadline to consummate a business combination by up to six additional months (from February 9, 2023 to August 9, 2023) (effective 2023-01-31).

“On January 31, 2023, the Company filed with the Secretary of State of the State of Delaware an amendment (the “ Extension Amendment ”) to the Company’s amended and restated certificate of incorporation to extend the date by which the Company must consummate a Business Combination up to six times, each by an additional month, for an aggregate of six additional months (i.e. from February 9, 2023 up to August 9, 2023) or such earlier date as determined by the board of directors.”

Orchestra BioMed Holdings, Inc.: Company ceased to be a shell company upon closing of the Business Combination.

“as a result of the Business Combination, the Company ceased to be a shell company upon the closing of the Business Combination.”

Orchestra BioMed Holdings, Inc.: Board approved and adopted a new Code of Business Conduct and Ethics (effective 2023-01-26).

“on January 26, 2023, the Board approved and adopted a new Code of Business Conduct and Ethics applicable to all employees, officers and directors of the Company.”

Orchestra BioMed Holdings, Inc.: Adopted new bylaws upon Domestication replacing prior governing documents.

“The bylaws of Domesticated HSAC2 became the bylaws of New Orchestra (the “Bylaws”).”

Orchestra BioMed Holdings, Inc.: Replaced memorandum and articles of association with new certificate of incorporation upon Domestication.

“Upon the effectiveness of the Domestication, HSAC2’s memorandum and articles of association in effect immediately prior to the Domestication were replaced with a certificate of incorporation and bylaws of Domesticated HSAC2, which continued in effect through the Closing. The certificate of incorporation of Domesticated HSAC2 became the certificate of incorporation of New Orchestra (the “Charter”).”

REVELATION BIOSCIENCES, INC.: Amended certificate of incorporation to increase authorized common shares from 100,000,000 to 500,000,000 and effect a 1-for-35 reverse stock split (effective 2023-02-01).

“On January 30, 2023, the Company filed a Certificate of Amendment of Third Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) reflecting the change in authorized shares of common stock from 100,000,000 to 500,000,000 and effecting a reverse stock split as of 12:01 a.m. Eastern Standard Time on February 1, 2023 with a ratio of 1-for-35”

Berry Corp (bry): 董事会采纳了第四次修订和重述的公司章程细则，更新了股东提名、业务提案通知等多项条款，并与其他法律修订保持一致。 (effective 2023-01-25).

“On January 25, 2023, the Board of Directors (the “Board”) of Berry Corporation (bry) (the “Company”) approved and adopted the Fourth Amended and Restated Bylaws of the Company (the “Bylaws”).”

Walgreens Boots Alliance, Inc.: Amended and restated bylaws effective immediately, including changes to stockholder lists, proxy card color, director nominations, abstentions, and emergency provisions (effective 2023-01-26).

“On January 26, 2023, the Board of Directors (the “Board”) of Walgreens Boots Alliance, Inc. (the “Company”), upon the recommendation of the Board’s Nominating and Governance Committee, approved and adopted, effective immediately, the Company’s Amended and Restated Bylaws (as amended and restated, the “Bylaws”).”

TXO Partners, L.P.: Adopted the Seventh Amended and Restated Agreement of Limited Partnership (effective 2023-01-31).

“On January 31, 2023, in connection with the closing of the Offering, the Sixth Amended and Restated Limited Partnership Agreement of MorningStar Partners, L.P. was amended and restated by the Seventh Amended and Restated Agreement of Limited Partnership of TXO Energy Partners, L.P. (as amended and restated, the “Partnership Agreement”).”

TXO Partners, L.P.: Amended and restated certificate of limited partnership to change name and designate general partner (effective 2023-01-31).

“Effective January 31, 2023, in connection with the closing of the Offering, the Certificate of Limited Partnership of MorningStar Partners, L.P. was amended and restated in order to (i) change the name of the Partnership to TXO Energy Partners, L.P. and (ii) designate the General Partner as the general partner of the Partnership (the “Amended and Restated Certificate of Limited Partnership”).”

BOLLINGER INNOVATIONS, INC.: Amendment to Certificate of Incorporation to increase authorized common stock from 1,750,000,000 to 5,000,000,000 shares and total authorized capital from 2,250,000,000 to 5,500,000,000 shares (effective 2023-01-30).

“On January 25, 2023, at the Special Meeting (as defined below), the Company’s stockholders approved an amendment (the “ Amendment ”) to Section A of Article III of the Company’s Second Amended and Restated Certificate of Incorporation (the “ Certificate of Incorporation ”) to increase the number of shares of authorized common stock, par value $0.001 per share (“ Common Stock ”), of the Company from 1,750,000,000 shares to 5,000,000,000 shares, with a corresponding increase in the Company’s total authorized capital stock, which includes Common Stock and Preferred Stock, from 2,250,000,000 shares to 5,500,000,000 shares. On January 30, 2023, the Company filed a Certificate of Amendment to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware implementing the Amendment.”

BOLLINGER INNOVATIONS, INC.: Cancellation of Series AA Preferred Stock Certificate of Designation, eliminating all Series AA Preferred Stock (effective 2023-01-30).

“On January 30, 2023, the Company filed a certificate of cancellation (the “ Certificate of Cancellation ”) with the Secretary of State of the State of Delaware, effective as of the time of filing, cancelling the Series AA Certificate of Designation, and thereby eliminating all Series AA Preferred Stock.”

BTCS Inc.: Created Series V Convertible Preferred Stock and filed Certificate of Designation with Nevada, amending the articles of incorporation.

“created a new series of convertible preferred stock, designated Series V Convertible Preferred Stock (the “Voucher”), and plans to distribute these Vouchers to each and every shareholder of record as of a to be announced record date.”